ロード中...
Standardizing total kidney volume measurements for clinical trials of autosomal dominant polycystic kidney disease
BACKGROUND: The ability of unstandardized methods to track kidney growth in clinical trials for autosomal dominant polycystic kidney disease (ADPKD) has not been critically evaluated. METHODS: The Tolvaptan Efficacy and Safety Management of ADPKD and its Outcomes (TEMPO) 3:4 study involved baseline...
保存先:
| 出版年: | Clin Kidney J |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6366146/ https://ncbi.nlm.nih.gov/pubmed/30746130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfy078 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|